Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ligand Pharmaceuticals to buy Neurogen for $11 million in stock, rights to future payouts
Ligand Pharmaceuticals to buy Neurogen for $11 million in stock, rights to future payouts
Ligand Pharmaceuticals to buy Neurogen for $11 million in stock, rights to future payouts
Submitted by
admin
on August 25, 2009 - 7:50am
Source:
Yahoo/AP
News Tags:
Ligand
Neurogen
M&A
Headline:
Ligand Pharmaceuticals to buy Neurogen for $11 million in stock, rights to future payouts
Do Not Allow Advertisers to Use My Personal information
